Time-restricted eating with calorie restriction on weight loss and cardiometabolic risk: a systematic review and meta-analysis
Sun JC, Tan ZT, He CJ, Hu HL, Zhai CL, Qian G
European journal of clinical nutrition · 35 citas
Cómo se estudió
- Diseño
- Metaanálisis (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- National Natural Science Foundation of China
- Gobierno
- Natural Science Foundation of Zhejiang Province
Según 2 financiadores declarados y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2023-07-24 · Eur J Clin Nutr · vol. 77 · número 11 · págs. 1014–1025
- Editorial
- Springer Nature
- Citado
- 43 citas · más que el 91% de estudios similares · 2.2× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 59 trabajos
- Acceso
- Acceso abierto (revista híbrida) · CC-BY
- Áreas de investigación
- Dietary Effects on Health · Diet and metabolism studies · Circadian rhythm and melatonin
- Palabras clave
- Meta-analysis, Calorie, Calorie restriction, Medicine, Weight loss, Obesity, Body mass index, Systematic review, MEDLINE, Environmental health, Internal medicine, Biology
- MeSH
- humans, cardiovascular diseases, body weight, weight loss, caloric restriction, blood pressure
6 autores
- Jing-Chao Sun🇨🇳Jiaxing University
- Zhen-Tao Tan🇨🇳Zhejiang Chinese Medical University; Jiaxing University
- Chao‐Jie He🇨🇳Jiaxing University
- Huilin Hu🇨🇳Jiaxing University
- Changlin Zhai🇨🇳Jiaxing University
- Gang Qian🇨🇳 · autor de correspondenciaJiaxing University; First Hospital of Jiaxing
Resumen
El texto original del estudio, en el idioma en que se publicó.
The effect of time-restricted eating (TRE) has been summarized in previous studies, but its benefits in combination with calorie restriction (CR) still need to be determined. The present meta-analysis aimed to evaluate the efficacy of TRE with CR on weight loss and cardiometabolic risk. PubMed, Embase, Cochrane Library, and gray literature databases were searched from inception to October 18, 2022, for potential randomized controlled trial (RCT) studies based on predefined inclusion and exclusion criteria. Body weight and other cardiometabolic risk factors were described as weighted mean difference (WMD) with a 95% confidence interval (CI). Eight RCTs involving 579 participants were enrolled in the present analysis. The pooled results showed that TRE with CR reduced the body weight, fat mass, and waist circumference significantly (WMD: -1.40, 95% CI: -1.81 to -1.00, and I2: 0%; WMD: -0.73, 95% CI: -1.39 to -0.07, and I2: 0%; WMD: -1.87, 95% CI: -3.47 to -0.26, and I2: 67.25%, respectively). However, compared with CR alone, TRE plus CR exhibited no significant benefit on the blood pressure, glucose profile, and lipid profile. Subgroup analysis suggested that early TRE is more effective in weight loss (WMD: -1.42, 95% CI: -1.84 to -1.01, and I2: 0%) and improving fat mass (WMD: -1.06, 95% CI: -1.91 to -0.22, and I2: 0%) than delayed or broader TRE when combined with CR. Although the combination of TRE and CR can effectively decrease body weight, fat mass, and waist circumference, the long-term effects, particularly those on cardiometabolic risk in participants with chronic cardiovascular disease and diabetes, remain to be explored.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.